P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

January 2010

Features

Q&A

An Interview Series with Members of the ASHP Expert Panel on Formulary Management

Part 3: Sabrina W. Cole, PharmD

In the third of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
C. Lee Ventola, MS

Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit

An order form for subcutaneous insulin was created to improve blood glucose control in hospitalized diabetic patients. Although use of the form by the staff was relatively low, teaching health care personnel about hyperglycemia and proper use of the form may help reduce complications after patient discharge.
Sally A. Arif, PharmD, BCPS; and Alisa K. Escaño, PharmD, BCPS, CDE

Alvimopan (Entereg) for the Management of Postoperative Ileus in Patients Undergoing Bowel Resection

Postoperative ileus is common after surgery, especially abdominal procedures. In clinical studies, alvimopan appeared to speed up gastrointestinal tract recovery, was associated with fewer adverse effects, and led to shorter hospital stays.
Michael Kraft, PharmD, BCNSP; Robert MacLaren, PharmD; Wei Du, PhD; and Gay Owens, PharmD

Meeting Highlights

American Heart Association, 2009 Scientific Sessions

Sessions covered the ARBITER 6-HALTS trial of ezetimibe (Zetia) and niacin (Niaspan); the HEAAL study of losartan (Cozaar); the relationships between statins, high-density lipoprotein-cholesterol (HDL-C) levels, and cardiovascular events; and the association of higher HDL-C levels with lower rates of breast cancer.
Walter Alexander

Pharmaceutical Approval Update

Topics include ecallantide (Kalbitor) for hereditary angioedema; a capsaicin 8% patch (Qutenza) for pain management; and romidepsin (Istodax) for patients with cutaneous T-cell lymphoma.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

Annual Evaluation

David B. Nash, MD, MBA, discusses his medication quality subcommittee’s annual assessment of its progress in promoting drug safety.
David B. Nash, MD, MBA

Medication Errors

Pumping up the Volume

Tips for Increasing Error Reporting

Matthew Grissinger, RPh, FASCP, provides suggestions to improve error-reporting systems.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Web of Confusion

FDA Tries to Clarify Rules for Internet Advertising

Stephen Barlas discusses the FDA’s attempt to clarify the rules on Internet advertising of drugs and medical devices.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From Agriflu vaccine to Zyprexa, P&T presents the latest studies and information about FDA approvals, drug indications, product recalls, and industry updates.

Drug Forecast

Vigabatrin (Sabril), a Gamma-Aminobutyric Acid Transaminase Inhibitor for the Treatment of Two Catastrophic Seizure Disorders

Dr. Martin Cruz reviews vigabatrin (Sabril), a therapy for seizure disorders.
Martin P. Cruz, PharmD, CGP, BCPP